image used as background

Innospec Achieves Gold Rating in Ecovadis Sustainability Assessment for the Fourth Consecutive Time

Englewood, Co – June 24, 2024 – Innospec (NASDAQ: IOSP) has been awarded a Gold rating in sustainability performance by EcoVadis, a leading provider of third-party sustainability evaluations.  Achieving a Gold rating ranks Innospec in the top 5% of all companies rated in our sector, globally.

Patrick S. Williams, President and Chief Executive Officer, said, “We are proud to again achieve Gold recognition from EcoVadis for our commitment to sustainable business practices.  Innospec will continue to explore new opportunities and innovative technologies to move our sustainability journey forward.”

Ian Callan, VP Global Regulatory Compliance and ESG, said, “At Innospec, we are dedicated to continually improving our sustainability performance.  We work hard to uphold the highest corporate responsibility standards, as reflected in our Gold EcoVadis rating.  Through working closely with our customers and suppliers, we ensure forward progress together.”


Independent platform for rating sustainability

EcoVadis is a globally recognised sustainability rating platform analysing data from over 180,000 companies in the fields of Environment and Climate, Labour and Human Rights, Ethics and Sustainable Procurement with the aim of providing a more transparent picture of how sustainability practices are successfully being put into practice. It uses a methodology aligned to CSR Standards such as the Global Reporting Initiative (GRI), UN Global Company and ISO 26000. The EcoVadis sustainability scorecards offer a detailed insight into ecological, social and ethical risks in 200 categories and 175 countries. The ratings are documented on an online platform and are available to the companies’ business partners among others.

To learn more about Innospec’s approach to sustainability, please read our latest report by visiting


About Innospec Inc.

Innospec Inc. is an international specialty chemicals company with approximately 2,400 employees in 22 countries. Innospec manufactures and supplies a wide range of specialty chemicals to markets in the Americas, Europe, the Middle East, Africa and Asia-Pacific.  The Performance Chemicals business creates innovative technology-based solutions for our customers in the Personal Care, Home Care, Agrochemical, Mining and Industrial markets. The Fuel Specialties business specializes in manufacturing and supplying fuel additives that improve fuel efficiency, boost engine performance and reduce harmful emissions. Oilfield Services provides specialty chemicals to all elements of the oil and gas exploration and production industry.


Forward-Looking Statements

This press release contains certain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.  All statements other than statements of historical facts included or incorporated herein may constitute forward-looking statements.  Such forward-looking statements include statements (covered by words like “expects,” “estimates,” “anticipates,” “may,” “could,” “believes,” “feels,” “plans,” “intends” or similar words or expressions, for example) which relate to earnings, growth potential, operating performance, events or developments that we expect or anticipate will or may occur in the future.  Although forward-looking statements are believed by management to be reasonable when made, they are subject to certain risks, uncertainties and assumptions, and our actual performance or results may differ materially from these forward-looking statements.  Additional information regarding risks, uncertainties and assumptions relating to Innospec and affecting our business operations and prospects are described in Innospec’s Annual Report on Form 10-K for the year ended December 31, 2023 and other reports filed with the U.S. Securities and Exchange Commission.  You are urged to review our discussion of risks and uncertainties that could cause actual results to differ from forward-looking statements under the heading “Risk Factors” in such reports.  Innospec undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.